Search clinical trials for: Bismuth containing quadruple therapy

Total 53540 results

M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Antibiotic Therapy and Antacids in Patients With Malt Lymphoma of the Stomach

Lymphoma

United States
Chungbuk National University Hospital

Completed

Empagliflozin-based Quadruple Combination vs Insulin Glarine-based Combination Therapy in Patients With Type 2 Diabetes

Diabetes Mellitus, Type 2
Gelderse Vallei Hospital
Wageningen University; Deventer Ziekenhuis

Completed

Nicotine Replacement Therapy in the Intensive Care Unit (NicGoWell)

Delirium | Psychomotor Agitation | Substance Withdrawal Syndrome | Nicotine Replacement Therapy

Netherlands
Daiichi Sankyo, Inc.

Completed

Patritumab With Cetuximab and a Platinum Containing Therapy for Patients With Head and Neck Cancer

Squamous Cell Carcinoma of the Head and Neck

United Kingdom
Shanghai Jiao Tong University School of Medicine

Completed

Tailored Therapy for Helicobacter Pylori Rescue Treatment

Helicobacter Pylori Infection

China
Bassett Healthcare

Withdrawn

Use of Bismuth Subsalicylate in Clostridium Difficile Colitis

Clostridium Difficile Infection

United States
Shandong University

Unknown

Antimicrobial Susceptibility Testing Guided Therapy Versus Empirical Therapy for the First-line Helicobacter Pylori Eradication.

Helicobacter Pylori Infection | Antimicrobial Susceptibility Testing

China
Shanghai Jiao Tong University School of Medicine

Completed

Clarithromycin Triple Therapy Plus Bismuth for Helicobacter Pylori First-line Treatment

Helicobacter Pylori Infection

China
National Taiwan University Hospital

Unknown

Sequential Versus Quadruple Therapy in the Second-line Treatment

Helicobacter Pylori Infection

Taiwan
Genethon
Hôpital Necker-Enfants Malades

Completed

Gene Therapy for WAS

Wiskott-Aldrich Syndrome

France
Novartis Pharmaceuticals
GlaxoSmithKline

Terminated

Single Agent Ofatumumab Vs. Single Agent Rituximab in Indolent B-Cell Non Hodgkin Lymphoma Relapsed After Rituximab-Containing Therapy (HOMER)

Non-Hodgkin's Lymphoma

China, United States, Belgium, Czechia, France, Japan, Bulgaria, Canada, Hungary, Peru, Slovakia, South Africa, Ukraine, Korea, Republic of, Puerto Rico, Brazil
Thammasat University

Unknown

Effectiveness of Once-daily Dose Regimen of 7-day and 14-day High Dose Rabeprazole-levofloxacin Based Quadruple Therapy for H. Pylori Eradication in Thai Patients With Non-ulcer Dyspepsia

Helicobacter Pylori Infection

Thailand
Ramathibodi Hospital

Completed

Once Daily Dose Dexlansoprazole Quadruple Therapy for Helicobacter Pylori

H Pylori Eradication

Thailand
Cairo University

Unknown

Intravitreal Diclofenac Versus Intravitreal Ranibizumab for the Treatment of Diabetic Macular Edema.

Diabetic Macular Edema

Egypt
Tanta University

Unknown

A Two Week Nitazoxanidebased Quadruple Regimen

Dyspepsia

Egypt
Janssen-Cilag International NV

Completed

A Clinical Trial Comparing the Efficacy of Darunavir/Ritonavir Monotherapy Versus a Triple Combination Therapy Containing Darunavir/Ritonavir and 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Patients With Undetectable Plasma HIV-1 RNA on Current Treatment (PROTEA)

Human Immunodeficiency Virus (HIV) Infections | Acquired Immunodeficiency Syndrome (AIDS) Virus

France, United Kingdom, Belgium, Germany, Spain, Switzerland, Denmark, Israel, Austria, Poland, Hungary, Sweden, Ireland
Penn State University
Procter and Gamble

Completed

Effect of Effect of a Medicated Topical Therapy , Petrolatum, and No Treatment on Nocturnal Cough

Respiratory Tract Diseases

United States
Kaohsiung Veterans General Hospital.

Completed

Concomitant, Sequential, and Standard Triple Therapy for H. Pylori Infection

Helicobacter Pylori Infection

Taiwan
Centre hospitalier de l'Université de Montréal...
Maisonneuve-Rosemont Hospital; Centre de Recherche du Centre Hospitalier de... and other collaborators

Completed

IMPACT-CABG Trial: IMPlantation of Autologous CD133+ sTem Cells in Patients Undergoing CABG (IMPACT-CABG)

Myocardial Infarct | Heart Failure

Canada
AbbVie

Completed

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ABT-493 and ABT-530 With and Without Ribavirin in Adults With HCV Who Failed a Prior DAA Containing Therapy

Chronic Hepatitis C | Hepatitis C Virus | HCV | Direct-Acting Antiviral Agent (DAA)-Experienced
Dr. Luis Fernandez

Unknown

Study of the Usefulness of the Probiotic 'Lactobacillus Reuteri' in the Therapy of Quadruple Eradication of Helicobacter Pylori Infection in Usual Clinical Practice.

Helicobacter Pylori Infection

Spain
Hui ting Xu，MD

Unknown

Clinical Study of Autologous Erythrocytes Derived MPs Packaging MTX Peritoneal Perfusion to Treat Malignant Ascites

Malignant Ascites

China
Assistance Publique - Hôpitaux de Paris

Unknown

Therapeutic Trial Comparing Triple Therapy Guided by the PCR Detection of Clarithromycin Resistance vs Empiric Concomitant Quadruple Therapy for Helicobacter Pylori Infection (Hepysé)

H Pylori Eradication | H Pylori Infection Eradication | Antibiotics Therapeutic Strategies

France
Kaohsiung Medical University Chung-Ho Memorial...

Completed

Adding Bismuth to Rabeprazole-based First-line Triple Therapy Does Not Improve the Eradication of Helicobacter Pylori

Helicobacter Pylori Infection
University of Southern California
National Cancer Institute (NCI)

Terminated

Dolasetron Mesylate and Dexamethasone With or Without Aprepitant in Preventing Nausea and Vomiting in Patients Undergoing Oxaliplatin-Containing Chemotherapy for Gastrointestinal Malignancy

Nausea and Vomiting | Malignant Digestive System Neoplasm

United States
UNC Lineberger Comprehensive Cancer Center
GlaxoSmithKline

Completed

Pazopanib In Stage IIIB/IV NSCLC Lung Cancer After Progression on First Line Therapy Containing Bevacizumab (LCCC0921)

Lung Cancer

United States
Forest Laboratories

Withdrawn

Safety, Efficacy of Pylera BID Dosing in Eradication of H. Pylori

Helicobacter Pylori Infection

United States, Canada
Hoffmann-La Roche

Completed

An Observational Study on Renal Function in Kidney Transplant Participants on Immunosuppressive Therapy Containing Mycophenolate Mofetil (ORANGE)

Kidney Transplantation

Hungary
Livzon Pharmaceutical Group Inc.

Completed

Efficacy and Safety of 1-week Triple Therapy With Ilaprazole for the Eradication of Helicobacter Pylori

Helicobacter Pylori Eradication
Institute of Tropical Medicine, Belgium
Liverpool School of Tropical Medicine; Kamuzu University of Health Sciences; Kwame... and other collaborators

Completed

Safe and Efficacious Artemisinin-based Combination Treatments for African Pregnant Women With Malaria (PREGACT)

Malaria in Pregnancy

Burkina Faso, Ghana, Malawi, Zambia
Shanghai Jiao Tong University School of Medicine

Completed

High Dose Amoxicillin Versus Tetracycline as Second-line Treatment of Resistant Helicobacter Pylori Infection

Helicobacter Pylori Treatment Failure

China
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Myeloid Cancer

Myelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative Neoplasms

United States
Kaohsiung Veterans General Hospital.
Baylor College of Medicine

Completed

Comparison of Sequential or Concomitant Therapy for Helicobacter Pylori Infection (960025)

Helicobacter Infection

Taiwan
Kaohsiung Veterans General Hospital.
Baylor College of Medicine; Kaohsiung Medical University

Completed

Sequential and Hybrid Therapies for H Pylori Infection

Helicobacter Pylori Infection

Taiwan
Yale University

Completed

Digestive Endoscopy Suite Radiation Controlling Protective Strategies (D-ERCP)

Radiation Exposure

United States
University of Arkansas
National Institutes of Health (NIH); Ortho Biotech Clinical Affairs, L.L.C.

Completed

Effects of Exercise in Combination With Epoetin Alfa

Multiple Myeloma

United States
The University of Hong Kong

Completed

A Study on the Efficacy and Safety of Continuous Renal Replacement Therapy (CVVHDF) Using a Commercial Citrate-containing Replacement Fluid (Prismocitrate 18/0)

Renal Failure

Hong Kong
Vertex Pharmaceuticals Incorporated

Completed

A Study to Evaluate the Efficacy and Safety of Quadruple Therapy (VX-222, Telaprevir,Peginterferon-Alfa-2a, Ribavirin) in Subjects With Chronic Hepatitis C With Compensated Cirrhosis

Chronic Hepatitis C Virus

United States, United Kingdom, Canada, Germany, Poland
National Taiwan University Hospital

Unknown

Efficacy of Acetylcysteine-containing Triple Therapy in the First Line of Helicobacter Pylori Infection

Helicobacter Pylori Infection

Taiwan
ANRS, Emerging Infectious Diseases
Bristol-Myers Squibb

Completed

Pilot Study to Assess the Efficacy of and Tolerance to a QUadruple Therapy to Treat HIV-HCV Coinfected Patients Previously Null Responders (QUADRIH)

HCV-HIV Co-Infection

France
Boehringer Ingelheim

Completed

Observational Study in Patients With HIV Infection Type 1 After Switching to a Viramune®-Containing Therapy Regimen

HIV Infections
Michael Schiff, MD
UCB Pharma

Completed

Can TNF-Alpha Incomplete Secondary Responders Attain a Safe and Efficacious Response Switching to Cimzia

Rheumatoid Arthritis

United States
University of Southern California

Completed

Intensified Post Remission Therapy Containing PEG-Asparaginase

Acute Lymphoblastic Leukemia

United States
American University of Beirut Medical Center

Completed

A Trial of Standard vs Half Dose Rabeprazole, Clarithromycin, Metronidazole and Amoxicillin in the Treatment of Helicobacter Pylori Infection

Helicobacter Infections

Lebanon
Chuncheon Sacred Heart Hospital

Terminated

Additive Effect of Endonase on Eradication Rate of Second Line Therapy for HP Infection

Helicobacter Pylori Infection

Korea, Republic of
Ontario Clinical Oncology Group (OCOG)
Hoffmann-La Roche

Completed

A Feasibility Study of Co-administering Combination Antiretroviral Therapy (cART) and R-EPOCH Chemotherapy for the Management of ARL (CATCH)

HIV Infections | Lymphoma, AIDS Related

Canada
Janssen-Cilag S.p.A.

Completed

A Study to Compare Brachial Artery Reactivity and Cardiovascular Risk of a Treatment Simplification by Darunavir/Ritonavir (DRV/r) 800/100 mg Versus a Triple Combination Therapy Containing DRV/r in HIV-1 Infected Patients (MONARCH)

Human Immunodeficiency Virus 1
ViiV Healthcare
GlaxoSmithKline

Completed

A Study To Assess GW433908 (Fosamprenavir) Containing Regimens In HIV-1 Infected Subjects

Infection, Human Immunodeficiency Virus

United States, Spain, France, United Kingdom, Chile, Brazil, Italy, Portugal
Shanghai Jiao Tong University School of Medicine

Completed

Quadruple Therapy Versus Dual Therapy as Rescue Regimens for Helicobacter Pylori Infection

Rescue Therapy for Helicobacter Pylori

China
AIO-Studien-gGmbH

Terminated

Study to Evaluate the Effects of Sorafenib if Combined With Chemotherapy (FOLFOX6 or FOLFIRI) in the Second-Line Treatment of Colorectal Cancer (FOSCO)

Colorectal Neoplasms

Germany

3

Subscribe